Clinical trial Recruiting at 9 sites Phase 2 Interventional Ages 18 to 45

Using metformin to reduce knee pain after ACL surgery

Official title: Preventing Injured Knees From osteoArthritis: Severity Outcomes (PIKASO)

Run by Brigham and Women's Hospital · NCT06096259 · Data updated 2026-11-12

This study is testing if metformin can help reduce knee pain and prevent arthritis in people recovering from ACL surgery.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment512 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations9 sites (Atlanta, Georgia and 8 other locations)
StatusRecruiting
StartedMay 6, 2024
Main results expectedDecember 2029
Study endsDecember 2030
Registry record updatedOctober 15, 2026
Trial IDNCT06096259 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-45 who plan to undergo ACL reconstruction within 12 months of their injury and have specific preoperative pain levels.

Probably not a fit

Patients with inflammatory arthritis, diabetes, or significant knee damage may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of metformin in reducing pain and delaying the onset of post-traumatic osteoarthritis (PTOA) following anterior cruciate ligament (ACL) reconstruction. Participants will be randomly assigned to receive either metformin or a placebo, which looks identical but contains no active medication. The study aims to determine if metformin's known anti-inflammatory properties can benefit individuals recovering from ACL injuries. By focusing on a specific age group and preoperative pain levels, the study seeks to identify those most likely to benefit from this intervention.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option to reduce pain and improve outcomes for patients recovering from ACL injuries.

How similar studies have gone: While metformin is primarily known for diabetes management, its anti-inflammatory effects suggest potential benefits in similar contexts, though this specific application is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 25-45 or Age 18-24 with preoperative KOOS Pain \<80 (0-100, 100 best) recorded at least 14 days after the day of ACL injury
2. Plan to undergo ACL reconstruction within 12 months of injury

Exclusion Criteria:

1. Inflammatory arthritis
2. Pregnancy and/or lactation, or plans to become pregnant in the next 12 months
3. Known contraindication to metformin
4. Current use of metformin or topiramate
5. Diabetes mellitus or diabetic ketoacidosis
6. Acute or chronic renal insufficiency
7. History of prior ACL tear on the index knee, with or without reconstruction
8. History of ACL tear on the contralateral knee within the past 12 months
9. Applying for or receiving Workers' Compensation for their knee injury
10. Joint space narrowing AND definite osteophyte(s) on weightbearing radiograph on index knee
11. Tibial plateau fracture on index knee
12. Concomitant avulsion fracture of index knee that will be treated surgically
13. Concomitant posterior cruciate ligament, medial collateral ligament, or lateral collateral ligament injury on index knee requiring surgical repair/reconstruction
14. Contraindication to MRI
15. Unable to speak and understand English
16. Diagnosis of cognitive impairment or otherwise unable to provide informed consent
17. Insufficient time for recruitment and drug titration: Surgery scheduled for \<14 days from the time of screening
18. Date of injury more than 6-months ago, relative to date of screening
19. Presence of a condition or abnormality that in the opinion of the surgeon investigator would compromise the safety of the patient or the quality of the data
20. Plan for allograft at time of consent

Where it's running

  • Emory University
    Atlanta, Georgia, United States
    Recruiting
  • University of Iowa Hospitals and Clinics
    Iowa City, Iowa, United States
    Recruiting
  • University of Kentucky
    Lexington, Kentucky, United States
    Recruiting
  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • University of Nebraska Medical Center
    Omaha, Nebraska, United States
    Recruiting
  • Hospital for Special Surgery
    New York, New York, United States
    Recruiting
Show 3 more locations
  • The University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • The Ohio State University
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.